These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


340 related items for PubMed ID: 7528102

  • 21. Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan.
    Deguchi Y, Okutsu H, Okura T, Yamada S, Kimura R, Yuge T, Furukawa A, Morimoto K, Tachikawa M, Ohtsuki S, Hosoya K, Terasaki T.
    J Neurochem; 2002 Oct; 83(2):381-9. PubMed ID: 12423248
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
    Moscatelli D.
    J Biol Chem; 1992 Dec 25; 267(36):25803-9. PubMed ID: 1464594
    [Abstract] [Full Text] [Related]

  • 25. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations.
    Reiland J, Rapraeger AC.
    J Cell Sci; 1993 Aug 25; 105 ( Pt 4)():1085-93. PubMed ID: 8227197
    [Abstract] [Full Text] [Related]

  • 26. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
    Larraín J, Alvarez J, Hassell JR, Brandan E.
    Exp Cell Res; 1997 Aug 01; 234(2):405-12. PubMed ID: 9260911
    [Abstract] [Full Text] [Related]

  • 27. Perlecan and tumor angiogenesis.
    Jiang X, Couchman JR.
    J Histochem Cytochem; 2003 Nov 01; 51(11):1393-410. PubMed ID: 14566013
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.
    Fannon M, Forsten KE, Nugent MA.
    Biochemistry; 2000 Feb 15; 39(6):1434-45. PubMed ID: 10684625
    [Abstract] [Full Text] [Related]

  • 30. Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate.
    Richardson TP, Trinkaus-Randall V, Nugent MA.
    J Biol Chem; 1999 May 07; 274(19):13534-40. PubMed ID: 10224122
    [Abstract] [Full Text] [Related]

  • 31. Heparan sulfate proteoglycans as transducers of FGF-2 signalling.
    Quarto N, Amalric F.
    J Cell Sci; 1994 Nov 07; 107 ( Pt 11)():3201-12. PubMed ID: 7699017
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC, Rahimi N, Forsten-Williams K, Nugent MA.
    Circ Res; 2004 Feb 20; 94(3):316-23. PubMed ID: 14684627
    [Abstract] [Full Text] [Related]

  • 34. Specific stimulation of basal lamina heparan sulfate proteoglycan in mouse uterine epithelium by Matrigel and by transforming growth factor-beta 1.
    Morris JE, Gaza G, Potter SW.
    In Vitro Cell Dev Biol Anim; 1994 Feb 20; 30A(2):120-8. PubMed ID: 8012654
    [Abstract] [Full Text] [Related]

  • 35. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: implication of cell-surface heparan sulphate proteoglycan endocytosis.
    Berrou E, Quarck R, Fontenay-Roupie M, Lévy-Toledano S, Tobelem G, Bryckaert M.
    Biochem J; 1995 Oct 15; 311 ( Pt 2)(Pt 2):393-9. PubMed ID: 7487873
    [Abstract] [Full Text] [Related]

  • 36. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z, Wang J, Cao R, Morita H, Soininen R, Chan KM, Liu B, Cao Y, Tryggvason K.
    Cancer Res; 2004 Jul 15; 64(14):4699-702. PubMed ID: 15256433
    [Abstract] [Full Text] [Related]

  • 37. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence.
    Carson DD, Tang JP, Julian J.
    Dev Biol; 1993 Jan 15; 155(1):97-106. PubMed ID: 8416848
    [Abstract] [Full Text] [Related]

  • 38. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK, Tran-Lundmark K, Soininen R, Tryggvason K, Thyberg J, Hedin U.
    Circ Res; 2004 Mar 05; 94(4):550-8. PubMed ID: 14739157
    [Abstract] [Full Text] [Related]

  • 39. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
    Sperinde GV, Nugent MA.
    Biochemistry; 1998 Sep 22; 37(38):13153-64. PubMed ID: 9748322
    [Abstract] [Full Text] [Related]

  • 40. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin.
    Gauer S, Schulze-Lohoff E, Schleicher E, Sterzel RB.
    Eur J Cell Biol; 1996 Jul 22; 70(3):233-42. PubMed ID: 8832207
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.